<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen L</submitter><funding>Jiangsu Provincial Medical Key Discipline</funding><funding>Changzhou Science and Technology Support Program</funding><funding>the Leading Talent of Changzhou“The 14th Five-Year Plan” High-Level Health Talents Training Project</funding><funding>Changzhou Science and Technology Project (Applied Based Research)</funding><funding>the National Natural Science Foundation of China</funding><funding>the Key R&amp;D Project of Jiangsu Province</funding><funding>Changzhou Science and Technology Project</funding><funding>the Leading Talent of Changzhou"The 14th Five-Year Plan" High-Level Health Talents Training Project</funding><funding>Changzhou Medical Center of Nanjing Medical University</funding><funding>the Key R&amp;amp;D Project of Jiangsu Province</funding><funding>Changzhou Clinical Medical Center</funding><funding>Prospective Research Program of Changzhou Xitaihu Development Foundation For Frontier Cell-Therapeutic Technology</funding><funding>Provincial-level Talent Program for National Center of Technology Innovation for Biopharmaceuticals</funding><pagination>25</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12801534</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs) are key regulators in tumor microenvironment and tumor immunity, partly through MHC-II expression that modulates T-cell differentiation. However, the upstream cytokine signals controlling MHC-II expression in fibroblasts still remain poorly defined.&lt;h4>Methods&lt;/h4>We examined MHC-II expression on fibroblasts under stimulation with interferon-γ (IFN-γ) and interleukin-1β (IL-1β) by using flow cytometry, transcriptomic analysis, and qRT-PCR. To dissect transcriptional regulation, we generated CIITA-overexpressing and CIITA-deficient fibroblast lines by lentiviral transduction and CRISPR/Cas9-mediated editing. Public scRNA-seq, ATAC-seq, and ChIP-seq datasets were further analyzed to validate molecular mechanisms.&lt;h4>Results&lt;/h4>IFN-γ robustly up-regulated MHC-II expression on fibroblasts, while IL-1β selectively suppressed this induction without affecting PD-L1. Mechanistically, IL-1β attenuated IFN-γ-induced CIITA expression at the mRNA level but did not alter STAT1 abundance or phosphorylation. Functional assays confirmed that CIITA was indispensable for IFN-γ-driven MHC-II expression in fibroblasts. Integration of transcriptomic and epigenomic data demonstrated that CIITA directly bound MHC-II gene promoters and regulated chromatin accessibility.&lt;h4>Conclusions&lt;/h4>Our study identifies an IFN-γ/STAT1/CIITA axis as the central regulator of MHC-II expression in fibroblasts and reveals IL-1β as a potent suppressor of this pathway. These findings highlight a novel cytokine-mediated regulatory mechanism underlying CAF-driven immunosuppression within the tumor microenvironment.</pubmed_abstract><journal>Cell communication and signaling : CCS</journal><pubmed_title>IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.</pubmed_title><pmcid>PMC12801534</pmcid><funding_grant_id>2022P010</funding_grant_id><funding_grant_id>82473269</funding_grant_id><funding_grant_id>32270955</funding_grant_id><funding_grant_id>BE2022719</funding_grant_id><funding_grant_id>CJ20250116</funding_grant_id><funding_grant_id>CE20235057</funding_grant_id><funding_grant_id>2024CZLJ009</funding_grant_id><funding_grant_id>YXZDXK202236</funding_grant_id><funding_grant_id>CZ20250020</funding_grant_id><funding_grant_id>CZZX202201</funding_grant_id><funding_grant_id>CZKYCMCC202301</funding_grant_id><funding_grant_id>BE2022721</funding_grant_id><funding_grant_id>NCTIB2024JS0101</funding_grant_id><funding_grant_id>2024P027</funding_grant_id><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Geng R</pubmed_authors><pubmed_authors>Fang Z</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Ma H</pubmed_authors><pubmed_authors>Lang Y</pubmed_authors><pubmed_authors>Tan B</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.</name><description>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs) are key regulators in tumor microenvironment and tumor immunity, partly through MHC-II expression that modulates T-cell differentiation. However, the upstream cytokine signals controlling MHC-II expression in fibroblasts still remain poorly defined.&lt;h4>Methods&lt;/h4>We examined MHC-II expression on fibroblasts under stimulation with interferon-γ (IFN-γ) and interleukin-1β (IL-1β) by using flow cytometry, transcriptomic analysis, and qRT-PCR. To dissect transcriptional regulation, we generated CIITA-overexpressing and CIITA-deficient fibroblast lines by lentiviral transduction and CRISPR/Cas9-mediated editing. Public scRNA-seq, ATAC-seq, and ChIP-seq datasets were further analyzed to validate molecular mechanisms.&lt;h4>Results&lt;/h4>IFN-γ robustly up-regulated MHC-II expression on fibroblasts, while IL-1β selectively suppressed this induction without affecting PD-L1. Mechanistically, IL-1β attenuated IFN-γ-induced CIITA expression at the mRNA level but did not alter STAT1 abundance or phosphorylation. Functional assays confirmed that CIITA was indispensable for IFN-γ-driven MHC-II expression in fibroblasts. Integration of transcriptomic and epigenomic data demonstrated that CIITA directly bound MHC-II gene promoters and regulated chromatin accessibility.&lt;h4>Conclusions&lt;/h4>Our study identifies an IFN-γ/STAT1/CIITA axis as the central regulator of MHC-II expression in fibroblasts and reveals IL-1β as a potent suppressor of this pathway. These findings highlight a novel cytokine-mediated regulatory mechanism underlying CAF-driven immunosuppression within the tumor microenvironment.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-01T03:13:03.434Z</modification><creation>2026-06-01T03:07:50.356Z</creation></dates><accession>S-EPMC12801534</accession><cross_references><pubmed>41366425</pubmed><doi>10.1186/s12964-025-02575-4</doi></cross_references></HashMap>